Neutrogena Oil Free Acne Wash Pink Grapefruit Facial Cleanser

Description

Neutrogena® is a dermatologist-recommended brand offering an oil-free acne wash formulated with 2% salicylic acid as an active acne treatment. This facial cleanser features MICROCLEAR® technology, which aids in clearing breakouts effectively. The product is enhanced with naturally derived grapefruit extract, contributing to its cleansing properties. It is presented in a 9.1 FL.OZ. (269 mL) container and is characterized by its pink grapefruit scent.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects associated with this medication.

Dosage and Administration

The product is intended for daily use. Prior to application, the user should wet the face thoroughly. A sufficient amount of the product should be dispensed onto the hands, followed by the addition of water to create a lather. The lather should then be gently massaged onto the face. It is essential to rinse the face thoroughly after massaging to ensure complete removal of the product.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

• Contact with eyes should be avoided; if contact occurs, the eyes must be flushed thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation is observed, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to avoid contact with the eyes. Should contact occur, patients should be instructed to flush the affected area thoroughly with water to minimize potential irritation or injury.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised that only one topical acne medication be utilized at a time to minimize the risk of irritation.

In addition, patients should avoid contact with the eyes; should contact occur, it is recommended to flush the eyes thoroughly with water.

This product is for external use only. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Oil Free Acne Wash Pink Grapefruit Facial Cleanser (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Neutrogena Oil-Free Acne Wash Pink Grapefruit Facial Cleanser in geriatric patients. The prescribing information does not indicate any dosage adjustments, safety concerns, or special precautions that are specifically applicable to elderly patients. Therefore, healthcare providers should exercise standard clinical judgment when recommending this product to geriatric patients, considering individual patient needs and conditions.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no explicit warnings or precautions regarding its use during pregnancy in the available data. As such, the potential risks to fetal outcomes remain unclear. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the benefits against any potential risks. It is advisable to monitor pregnant patients closely if the product is deemed necessary for use during pregnancy.

Lactation

The safety of this product during lactation has not been established. There is a potential for excretion in breast milk; therefore, caution should be exercised when administering this product to nursing mothers.

Renal Impairment

There is no information available regarding renal impairment, including dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of specific guidance when treating patients with renal impairment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the provided text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should instruct patients to avoid contact with the eyes. If contact does occur, patients should be advised to flush the eyes thoroughly with water to mitigate any potential irritation.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. Proper handling should be observed to ensure optimal conditions are met throughout the storage period.

Additional Clinical Information

The medication is administered topically and is intended for daily use. Clinicians should counsel patients that the product is for external use only and advise against simultaneous use with other topical acne medications, as this may increase the likelihood of skin irritation and dryness. In the event of irritation, patients should limit their use to one topical acne treatment at a time.

Patients should be instructed to avoid contact with the eyes; if contact occurs, they should flush the area thoroughly with water. Additionally, the medication should be kept out of reach of children, and in the case of accidental ingestion, medical assistance or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Neutrogena Oil Free Acne Wash Pink Grapefruit Facial Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)